NF279: a novel potent and selective antagonist of P2X receptor-mediated responses

By Damer S.   Niebel B.   Czeche S.   Nickel P.   Ardanuy U.   Schmalzing G.   Rettinger J.   Mutschler E.   Lambrecht G.  

European Journal of Pharmacology, Vol. 350, Iss. 1, 1998-05 ,pp. : 5-6

Elsevier

Access to resources Recommend Favorite

The (S)-(+)-enantiomer of dimethindene: a novel M 2 -selective muscarinic receptor antagonist

By Pfaff O.   Hildebrandt C.   Waelbroeck M.   Xue H.   Moser U.   Mutschler E.   Lambrecht G.  

European Journal of Pharmacology, Vol. 286, Iss. 3, 1995-11 ,pp. : 229-240

Elsevier

Access to resources Recommend Favorite

ET_A-receptor blockade impairs vasoconstriction after hemorrhage in xenon-anesthetized dogs treated with an AT₁-receptor antagonist

By Höhne Claudia   Francis Roland C.E.   Pickerodt Philipp   Klein Adrian   Kaisers Udo   Boemke Willehad  

Canadian Journal of Physiology and Pharmacology, Vol. 86, Iss. 6, 2008-06 ,pp. : 373-379

NRC Research Press

Access to resources Recommend Favorite

Effect of a novel NK 1 receptor selective antagonist (NKP608) on citric acid induced cough and airway obstruction

By El-Hashim A.Z.   Wyss D.   Lewis C.  

Pulmonary Pharmacology & Therapeutics, Vol. 17, Iss. 1, 2004-02 ,pp. : 11-18

Elsevier

Access to resources Recommend Favorite

Prolonged Anti-Hypertensive Effects of Oral Sitaxsentan, a Selective ET_A Endothelin Receptor Antagonist, in Spontaneoulsy Hypertensive Hamsters

By Rubinstein Israel  

Cardiovascular Drugs and Therapy, Vol. 20, Iss. 5, 2006-10 ,pp. : 387-390

Springer Publishing Company

Access to resources Recommend Favorite